Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin
Forbes, C.D.
British Journal of Clinical Practice 43(11): 396-400
1989
ISSN/ISBN: 0007-0947 PMID: 2558702 Document Number: 332737
Document emailed within 1 workday
Related Documents
Akanmu, A.S.; Nnodu, O.E.; Giwa, S.O.; Salako, L.A.; Akinsete, I.; Adebule, G.T.; Adekoya-Cole, T.O.; Odunubi, O.O. 2004: Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery African Journal of Medicine and Medical Sciences 33(4): 335-340Yang, Z.; Liu, X.; Dai, S.; Liu, K.; Zhang, Y.; Sun, J.; Yin, X. 2010: Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(9): 1058-1061
Alonso Martínez, J.L.; Abínzano Guillén, M.L.; Urbieta Echezarreta, M.A.; Annichérico Sánchez, F.J.; Fernández Ladrón, V.; García Sanchotena, J.L. 2008: Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis Anales de Medicina Interna 25(1): 4-8
Labas, P.; Ohrádka, B.; Vladimír, J.; Cambal, M. 2000: The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression International Angiology: a Journal of the International Union of Angiology 19(4): 303-307
Savage, K.J.; Wells, P.S.; Schulz, V.; Goudie, D.; Morrow, B.; Cruickshank, M.; Kovacs, M.J. 1999: Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity Thrombosis and Haemostasis 82(3): 1008-1010
Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F.; Blümel, G. 1987: Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittel-Forschung 37(7): 839-843
Zidane, M.; van Hulsteijn, L.H.; Brenninkmeijer, B.J.; Huisman, M.V. 2006: Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice Haematologica 91(8): 1052-1058
Hull, R.D.; Pineo, G.F.; Stein, P.D.; Mah, A.F.; MacIsaac, S.M.; Dahl, O.E.; Ghali, W.A.; Butcher, M.S.; Brant, R.F.; Bergqvist, D.; Hamulyák, K.; Francis, C.W.; Marder, V.J.; Raskob, G.E. 2001: Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review Archives of Internal Medicine 161(16): 1952-1960
Barrellier, M.T.; Le Hello, C.; Verfaille, M.; Vignon, C.; Bertin, T.; Boissel, M.; Dubois, F.; Fauchon, G.; Pegoix, M.; Thomassin, C.; Trahay, A.; Aubriot, J.H.; Vielpeau, C. 2000: Echo-doppler monitoring of asymptomatic distal deep vein thrombosis in patients given low-molecular-weight-heparin at prophylactic doses after orthopedic surgery Journal des Maladies Vasculaires 25(3): 195-200
Levine, M.N.; Planes, A.; Hirsh, J.; Goodyear, M.; Vochelle, N.; Gent, M. 1989: The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement Thrombosis and Haemostasis 62(3): 940-944
Boccalon, H.; Elias, A.; Chalé, J.J.; Cadène, A.; Gabriel, S. 2000: Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study Archives of Internal Medicine 160(12): 1769-1773
Turpie, A.G.; Levine, M.N.; Hirsh, J.; Carter, C.J.; Jay, R.M.; Powers, P.J.; Andrew, M.; Magnani, H.N.; Hull, R.D.; Gent, M. 1987: Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke Lancet 1(8532): 523-526
Fluh, D. 1990: Clinical monitoring and prevention of deep vein thrombosis in an orthopedic department: use of enoxaparin for a year Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 31(3): 151-153
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294
Nesvold, A.; Ly, B.; Abildgaard, U.; Stiris, M. 1991: Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(27): 3296-3297
Volteas, S.K.; Kalodiki, E.; Nicolaides, A.N. 1996: Low molecular weight heparins in the initial treatment of deep vein thrombosis International Angiology: a Journal of the International Union of Angiology 15(1): 67-74
Stephan, D.; Welsch, M.; Chapatte, D.; Weltin, D.; Imbs, J.L. 1999: Deep venous thrombosis during pregnancy: long-term treatment with low molecular weight heparin Presse Medicale 28(34): 1880
Kettunen, K.; Poikolainen, E.; Karjalainen, P.; Oksala, I.; Alhava, E.; Rehnberg, V.; Huttunen, H.; Mattila, M. 1974: Prevention of postoperative deep vein thrombosis with small doses of heparin Duodecim; Laaketieteellinen Aikakauskirja 90(11): 834-838
Lamy, O.; Cornuz, J.; Yersin, B. 1999: Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review Schweizerische Medizinische Wochenschrift 129(18): 707-714
Clark-Pearson, D.L.; DeLong, E.; Synan, I.S.; Soper, J.T.; Creasman, W.T.; Coleman, R.E. 1990: A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis Obstetrics and Gynecology 75(4): 684-689